STUDresearch · Non-peptide
Acarbose
Also known as
Precose · Glucobay
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Non-peptide
Some talk
Mixed
Oral
Longevity / cellular
Mixed — Primarily gut-local enzyme block with systemic glucose effects.
What people say
Acarbose slows carbohydrate digestion. People discuss smaller post-meal glucose spikes and longevity experiments, with gas and gut tolerance often the practical sticking point.
Doses people talk about
Medical and longevity use have different goals. These ranges describe existing notes, not a personal dosing plan.
How it may feel
Gas, bloating or gut discomfort may be more noticeable than a benefit. A meal's glucose change is not always something a person can feel.
Meal-time amounts discussed25–100 mg orally with a meal
Oral tablets; community discussion varies with meals and gut tolerance.
Half-life & effect duration
- Half-life in the body
- Measured blood activityAbout 2 hours
- Felt duration people report
- After a mealGas lasting the rest of the day in one account; little effect after other meals
- With longer useSome report the gas fading
Cycles people discuss
Discussion includes ongoing meal-linked use and weeks-on/weeks-off experiments around cost or gut tolerance. There is no single established community cycling calendar.
Timing
The labeled oral product is linked to the first bite of a main meal. Community notes focus on food choices, meal size and gut symptoms, not a fixed all-day effect window.
Stacks
Metformin / rapa lore: Sometimes discussed in multi-agent longevity stacks — confounded.
Watch for
GI gas/bloating: Very common — undigested carbs ferment.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
About 2 hours for acarbose activity measured in plasma.
Acarbose mainly acts in the gut. This blood measurement is not a two-hour limit on meal effects or gas.
Label distinguishes active parent/metabolite activity from total drug-related radioactivity. Little active drug is absorbed; historical IV research is not an injectable-use instruction.
- Acarbose label: local gut action and plasma activity (opens in a new tab)Clinical Pharmacology, Mechanism of Action and Pharmacokinetics: Absorption, Metabolism and Excretion.Active-drug activity, metabolites and total radioactivity are different endpoints; oral product context.
Felt duration people report
One new user reports gas lasting the rest of the day after a meal, but little effect after other meals. Some longer-term users say the gas eventually fades.
Food and other supplements vary. Less gas is not proof that glucose effects or a claimed longevity benefit have changed.
HigoMe33 was three days into use and also used rapamycin and supplements. Tom_Clark changed fermented foods and described unusually high amounts; LukeMV reports long-term adaptation without an exact onset date. No dosing or microbiome theory is adopted.
- Acarbose in a first-person longevity log (opens in a new tab)HigoMe33, post 58, April 3, 2023: Acarbose subsection, three days of use and contrasting meals.Rapa, supplements and diet confound; the post's procurement, dosing advice and mechanistic guesses are not adopted.
- Acarbose: later changes in gas reporting (opens in a new tab)Tom_Clark post 7 and LukeMV post 8, January 7, 2026; Tom's post 11 distinguishes speculation about effectiveness.Uncontrolled reports; high amounts and fermented-food changes confound. The quoted AI microbiome explanation is not verified evidence.
Other context in this card
- Acarbose tablets: meal and storage context (opens in a new tab)DailyMed Acarbose: Dosage and Administration, How Supplied/Storage, Clinical Pharmacology. Actual bounded label inspection September 6.U.S. tablet labeling; does not authenticate internet products or establish longevity benefit.
What people say
- Healthspan narrative: Acarbose is discussed for aging markers, energy, or recovery more than acute gym pumps. forum
- Slow endpoints: Users often run months, not days, before claiming anything — and still confabulate. anecdote
- Stack noise: Frequently combined with multi-agent longevity stacks that destroy attribution. forum
- Post-meal glucose: Blunts postprandial glucose spikes by delaying complex carb breakdown. trial
- Longevity lore: Rodent ITP-style interest; human longevity outcome data is not a slam-dunk anti-aging claim. animal
Doses people talk about
- Longevity charts: Some protocols discuss lower meal doses; not a universal standard. forum
- Quality flag: Community notes raise gray-market fill and identity concerns; the label alone does not verify a particular product. The original claim that fill errors are common is not a measured prevalence estimate. forum
- Lower-amount discussion: Some experiment accounts describe beginning at the lower end of a chart to judge gut tolerance. One longevity poster summarizes 25 mg snacks and 50 or 100 mg meals as what others do; his own specific meal account used 50 mg. These are reports, not a starting rule. forum
- Product quality: Gray-market fill accuracy and identity are uncertain; dose math assumes the label is true. forum
- Route boundary: The labeled product and inspected meal reports concern oral tablets. Older notes warn against oral/SC/nasal milligram equivalence; they do not establish those other routes for Acarbose. trialforum
- Medical bands: Often discussed 25–100 mg with meals depending on titration and tolerance. trial
- Framing: All figures are discussed trial, clinic, or community amounts — research/educational only, not prescriptions. forum
How it may feel
- Early oral experiences: Gas, bloating or other gut symptoms may be more noticeable than any glucose change. Acarbose tablets are oral; injection-site reactions do not describe this product. forumtrial
- Day 1: Meal timing and gut effects are more relevant to oral Acarbose than an injection sting or a dramatic immediate benefit. forumtrial
- Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
- Weeks 1–2: First honest checkpoint in self-logs. forum
- Meals: Effect is meal-tied — take with first bites of carb-containing meal in medical instructions. trial
Cycles people discuss
- Pattern: Meal-time continuous use; GI tolerance drives real-world adherence. forum
- Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Adverse-effect reassessment: Community discussion includes stopping and reassessing when adverse effects appear; these accounts are not medical care. forum
Timing
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Action: Local gut enzyme inhibition more than long plasma “half-life story.” trial
- Published PK: Where human PK exists it should override forum half-life memes for Acarbose. trial
More on what it is
- Why biohackers care: NIA Interventions Testing Program and “carb blocker at meals” longevity talk. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- What it is: Oral alpha-glucosidase inhibitor (Precose/Glucobay) delaying carb digestion; longevity/ITP interest plus T2D use. trial
- Not a peptide: Small molecule drug — Non-peptide. trial
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- Metformin / rapa lore: Sometimes discussed in multi-agent longevity stacks — confounded. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- Finished oral product: The reviewed Acarbose label concerns tablets, not peptide-vial reconstitution. STUDresearch does not provide diluent volumes or syringe-unit charts; variable preparations do not validate an injectable equivalent. trialforum
- Tablet storage: The reviewed label specifies 20–25°C (68–77°F), protection from moisture and a tightly closed container. Older cool/dry/away-from-light seller notes remain general handling discussion, not verification of a nonstandard product or a universal after-opening rule. trialforum
Watch for
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
- GI gas/bloating: Very common — undigested carbs ferment. trial
- Hypoglycemia risk: Mainly when combined with other glucose-lowering drugs. trial
- Route boundary: This card concerns oral Acarbose. It is not an injectable-peptide profile; injection-site technique notes must not imply that these tablets are injected. trial
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.